Last 6 hoursStory cluster

FDA Approvals Highlight Advances in Gene Therapy and Oncology

2 sources · 0 editorials2 factsMay 14 – May 14, 2026

Source coverage

Original publisher articles in this cluster. Broadside has not yet written editorial coverage.

Regenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approval

via endpoints.news1 day ago

BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta

via endpoints.news1 day ago

← Back to home